Board Review Bonus #3: Lupus Nephritis
In this Board Review Bonus episode of GN in Ten, hosts Dr. Kenar Jhaveri (Northwell Health/Hofstra University) and Dr. Koyal Jain (UNC Chapel Hill) dive into the crucial topic of Lupus Nephritis. Special guest, Northwell fellow Dr. Mahmoud Abdelaziz, asks Kenar and Koyal the tough questions about key topics in diagnosing and managing LN.
Tune in to learn about diagnosis and initial suspicion of kidney involvement in Systemic Lupus Erythematosus (SLE), the six histological classifications (Class I-VI) of lupus nephritis, and an overview of induction and maintenance treatment algorithms for Class III and IV (proliferative) and Class V (membranous) lupus nephritis, including the use of reduced-dose glucocorticoids, MMF, cyclophosphamide (Euro-lupus vs. NIH protocols), and newer agents like voclosporin and belimumab. The GN in Ten hosts also discuss essential supportive care, like pneumocystic pneumonia prophylaxis (and the associated controversy with sulfamethoxazole/trimethoprim), multidisciplinary management, and management of special situations like pregnancy and Thrombotic Microangiopathy (TMA).
Referenced Resources and Studies:
KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis
American College of Rheumatology (ACR) Guidelines for Lupus Nephritis and Systemic Lupus Erythematosus
Euro-Lupus Nephritis Trial and Protocol
NIH Lupus Nephritis Trial and Protocol
LUNAR Trial
Tune in to learn about diagnosis and initial suspicion of kidney involvement in Systemic Lupus Erythematosus (SLE), the six histological classifications (Class I-VI) of lupus nephritis, and an overview of induction and maintenance treatment algorithms for Class III and IV (proliferative) and Class V (membranous) lupus nephritis, including the use of reduced-dose glucocorticoids, MMF, cyclophosphamide (Euro-lupus vs. NIH protocols), and newer agents like voclosporin and belimumab. The GN in Ten hosts also discuss essential supportive care, like pneumocystic pneumonia prophylaxis (and the associated controversy with sulfamethoxazole/trimethoprim), multidisciplinary management, and management of special situations like pregnancy and Thrombotic Microangiopathy (TMA).
Referenced Resources and Studies:
KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis
American College of Rheumatology (ACR) Guidelines for Lupus Nephritis and Systemic Lupus Erythematosus
Euro-Lupus Nephritis Trial and Protocol
NIH Lupus Nephritis Trial and Protocol
LUNAR Trial
Creators and Guests
Host
Kenar Jhaveri
Chair, ISGD Education Committee. Nephrologist Educator, Rapidly Progressive Glomerular Nephrologist, onconephrologist, cyclist 🚴♀️, runner 🏃 Editor in chief: ASN Kidney News
Host
Koyal Jain
ISGD Education Committee Co-Chair | PD @UNCkidney | Director of UME @UNCDeptMedicine | Glomerular Diseases and Vasculitis | Medical Education | Tweets are my own
Guest
Dr. Mahmoud Abdelaziz
Alumni, Fellowship in Nephrology at North Shore University | Internal Medicine and Nephrology